Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kevin, Sojourner"'
Autor:
Hewa Artin, Sean Bentley, Eamonn Mehaffey, Fred X. Liu, Kevin Sojourner, Andrew W. Bismark, David Printz, Ellen E. Lee, Brian Martis, Sharon De Peralta, Dewleen G. Baker, Jyoti Mishra, Dhakshin Ramanathan
Publikováno v:
EClinicalMedicine, Vol 48, Iss , Pp 101439- (2022)
Summary: Background: (S)-ketamine is a glutamatergic drug with potent and rapid acting effects for the treatment of depression. Little is known about the effectiveness of intranasal (S)-ketamine for treating patients with comorbid depression and post
Externí odkaz:
https://doaj.org/article/242ecd618d914a6eae1532cfd7779b8a
Autor:
Sean Bentley, Hewa Artin, Eamonn Mehaffey, Fred Liu, Kevin Sojourner, Andrew Bismark, David Printz, Ellen E. Lee, Brian Martis, Sharon De Peralta, Dewleen G. Baker, Jyoti Mishra, Dhakshin Ramanathan
Publikováno v:
Pharmacotherapy, vol 42, iss 3
BackgroundRacemic (R,S)-ketamine is a glutamatergic drug with potent and rapid acting antidepressant effects. An intranasal formulation of (S)-ketamine was recently approved by the US Food and Drug Administration (FDA) to be used in individuals with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::425eb71e46a1a3534d997028160fe90a
https://doi.org/10.1002/phar.2664
https://doi.org/10.1002/phar.2664
Autor:
Hewa, Artin, Sean, Bentley, Eamonn, Mehaffey, Fred X, Liu, Kevin, Sojourner, Andrew W, Bismark, David, Printz, Ellen E, Lee, Brian, Martis, Sharon, De Peralta, Dewleen G, Baker, Jyoti, Mishra, Dhakshin, Ramanathan
Publikováno v:
EClinicalMedicine. 48
(We performed a retrospective case series analysis of clinical outcomes in 35 Veterans with co-morbid depression and PTSD who were treated with intranasal (During the induction phase of treatment there was an absolute reduction of 5.1 (SEM 0.7) on th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1bb7867768e58d3d776c1741772810c7
https://pubmed.ncbi.nlm.nih.gov/35706484
https://pubmed.ncbi.nlm.nih.gov/35706484
Autor:
Dhakshin S. Ramanathan, Hewa Artin, Sean Bentley, Fred X. Liu, David Printz, Jyoti Mishra, Sharon De Peralta, Brian Martis, Dewleen G. Baker, Kevin Sojourner, Andrew W. Bismark, Eamonn Mehaffey, Ellen E. Lee
Publikováno v:
SSRN Electronic Journal.
Objective: Ketamine is a glutamatergic drug with potent and rapid acting effects for the treatment of depression. Little is known about the effectiveness of intranasal (S)-ketamine for treating patients with comorbid depression and PTSD. Methods: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0532b34ddd5baa71482429e6aefe79cf
https://doi.org/10.2139/ssrn.3928508
https://doi.org/10.2139/ssrn.3928508